Erratum: Immune-mediated thrombotic thrombocytopenic purpura following mRNA-based COVID-19 vaccine BNT162b2: Case report and mini-review of the literature
Main Author: | Frontiers Production Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1186494/full |
Similar Items
-
Hereditary Thrombotic Thrombocytopenic Purpura
by: Sanober Nusrat, et al.
Published: (2023-10-01) -
Vaccination and Thrombotic Thrombocytopenic Purpura
by: İrfan Yavaşoğlu
Published: (2020-08-01) -
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature
by: Vanessa Alexandra Buetler, et al.
Published: (2022-05-01) -
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
by: Mawaddah Alislambouli, et al.
Published: (2022-02-01) -
Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: a short review and update
by: Zoe Markham-Lee, et al.
Published: (2023-01-01)